CliffBio

Collegium Pharmaceutical

Patent cliffs & loss of exclusivity

A company developing products for pain management

Company

AngelList URLhttps://angel.co/collegium-pharmaceutical
Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/collegium-pharmaceutical
Email format{f}{last}
Full Address100 Technology Center Dr, Stoughton, Massachusetts 02072, US
LinkedIn URLhttp://www.linkedin.com/company/collegium-pharmaceutical
Pitchbook URLhttps://pitchbook.com/profiles/company/42162-13
Public/PrivatePublic

14 upcoming patent cliffs

DrugIngredientTypeCliff
  1. NUCYNTATAPENTADOL HYDROCHLORIDESmall mol.Jan 2027
  2. NUCYNTATAPENTADOL HYDROCHLORIDESmall mol.Jan 2027
  3. NUCYNTATAPENTADOL HYDROCHLORIDESmall mol.Jan 2027
  4. NUCYNTATAPENTADOL HYDROCHLORIDESmall mol.Jan 2027
  5. NUCYNTA ERTAPENTADOL HYDROCHLORIDESmall mol.Mar 2029
  6. NUCYNTA ERTAPENTADOL HYDROCHLORIDESmall mol.Mar 2029
  7. NUCYNTA ERTAPENTADOL HYDROCHLORIDESmall mol.Mar 2029
  8. NUCYNTA ERTAPENTADOL HYDROCHLORIDESmall mol.Mar 2029
  9. NUCYNTA ERTAPENTADOL HYDROCHLORIDESmall mol.Mar 2029
  10. XTAMPZA EROXYCODONESmall mol.Sep 2036
  11. XTAMPZA EROXYCODONESmall mol.Sep 2036
  12. XTAMPZA EROXYCODONESmall mol.Sep 2036
  13. XTAMPZA EROXYCODONESmall mol.Sep 2036
  14. XTAMPZA EROXYCODONESmall mol.Sep 2036

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.